itolizumab
Showing 1 - 4 of 4
Dermatomyositis, Adult Type Trial (Itolizumab)
Not yet recruiting
- Dermatomyositis, Adult Type
- Itolizumab
- (no location specified)
Aug 3, 2023
Acute Respiratory Distress Syndrome Trial (Itolizumab)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Itolizumab
- (no location specified)
Aug 3, 2023
Acute GVHD Trial (Itolizumab, Methylprednisolone)
Not yet recruiting
- Acute Graft Versus Host Disease
- Itolizumab
- Methylprednisolone
- (no location specified)
Apr 10, 2023
GVHD, GVHD, Acute-graft-versus-host Disease Trial in Canada, United States (Itolizumab, EQ001 Placebo)
Recruiting
- Graft Versus Host Disease
- +4 more
- Itolizumab
- EQ001 Placebo
-
Duarte, California
- +5 more
Jul 5, 2022